The cannabis industry is unique, but the basics of running a business well enough for success still apply. Investors want to see companies with solid management, good community outreach and serious plans for growth.
As with any investment, VCs benefit from researching the company and market they are planning to invest in. In addition to making sure they have a thorough understanding of the business model and its value proposition, investors should also familiarize themselves with the company’s management team to make sure that they are knowledgeable and experienced in both running a company and the cannabis industry.
Those who have implemented RegTech will have distinct advantages. To survive and thrive in the industry going forward, it’s prudent to proactively handle compliance and adopt RegTech solutions today.
From hobbyist producers operating out of home kitchens to opportunists using flex-industrial spaces, there are some issues to look out for in how CBD products are produced. Manufacturers need to adhere to a number of standards and best practices to protect consumer safety and ensure a quality final product.
With any new trend or shift in the labor and job landscape, it’s natural to be cautious of how it may affect you or your workers, both personally and professionally. Automation is here to help though, not hurt.
We looked at 10 major pharmaceutical companies and 10 major cannabis companies, comparing what positions they had for scientists and their R&D spending. Why are scientists rarely in the c-suite of cannabis companies?
When it comes to cannabis pathogen testing, facts are more important than comfort. In this piece, Dr. Hom advocates for qPCR over plating methods when conducting microbiology testing in cannabis
Milan Patel, CEO and co-founder of PathogenDx, shares insights on the current state of cannabis testing in the U.S., where we’re falling short, and how we can right the trajectory of the industry by establishing better testing procedures.
Until cannabis is federally legalized and given oversight, fraud in the laboratory setting is a persistent issue. How that regulation protects the American consumer is up to the work of the industry and what we continue to prioritize.
With a new year comes new opportunities and challenges for cannabis. From international market expansion to new technologies, see what Chistov thinks might be in store for 2022.